Mangrove Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
GCL
SCM
PC
HI
Mangrove Partners's AONC Position: Q1 2022 in Review
Mangrove Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2022, closing a stake of 100,000 shares — an estimated $975K sold.
Mangrove Partners first reported a position in AONC in Q2 2021 and held it in 3 quarters. The position peaked at $975K in Q4 2021. 65 funds tracked by Wall St. Rank hold AONC as of Q1 2022.
- Mangrove Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
- Mangrove Partners sold 100,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2022, an estimated $975K.
- Mangrove Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 3 quarters.
- Mangrove Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $975K in Q4 2021.
- 65 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2022.
Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.